These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14594555)

  • 1. Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer.
    Bardakci F; Canbay E; Degerli N; Coban L; Canbay EI
    J Cell Mol Med; 2003; 7(3):307-12. PubMed ID: 14594555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GSTM1 gene polymorphism in patients with head and neck tumors].
    Gronau S; König-Greger D; Rettinger G; Riechelmann H
    Laryngorhinootologie; 2000 Jun; 79(6):341-4. PubMed ID: 10923314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
    Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1].
    Li L; Lin P; Deng YF; Zhu ZL; Lu HH
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):2-7. PubMed ID: 15127559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and phenotype of glutathione-S-transferase in patients with head and neck carcinoma.
    Konig-Greger D; Riechelmann H; Wittich U; Gronau S
    Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15195058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1.
    Risch A; Ramroth H; Raedts V; Rajaee-Behbahani N; Schmezer P; Bartsch H; Becher H; Dietz A
    Pharmacogenetics; 2003 Apr; 13(4):225-30. PubMed ID: 12668919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk.
    Jourenkova-Mironova N; Voho A; Bouchardy C; Wikman H; Dayer P; Benhamou S; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):185-8. PubMed ID: 10067818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher glutathione transferase GSTM1 0/0 genotype frequency in young thyroid carcinoma patients.
    Canbay E; Dokmetas S; Canbay EI; Sen M; Bardakci F
    Curr Med Res Opin; 2003; 19(2):102-6. PubMed ID: 12740153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
    Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
    Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
    Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.
    Bell DA; Taylor JA; Paulson DF; Robertson CN; Mohler JL; Lucier GW
    J Natl Cancer Inst; 1993 Jul; 85(14):1159-64. PubMed ID: 8320745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase M1 and T1 status and the risk of laryngeal cancer: a meta-analysis.
    Kumar V; Murthy AK; Suresh KP
    Asian Pac J Cancer Prev; 2011; 12(9):2221-6. PubMed ID: 22296360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.